Phase II study of vinorelbine in heavily previously treated small cell lung cancer. Japan Lung Cancer Vinorelbine Study Group

Oncology
K FuruseH Niitani

Abstract

Twenty-four previously treated patients with refractory or relapsed small cell lung cancer (SCLC) were entered into a prospective, multicenter phase II study. All 24 patients had been pretreated with some form of cisplatin-based chemotherapy. The median time of chemotherapy was 4.2 months (range 1.4-9.4 months). Patients were treated with a dose of 25 mg/m2 of vinorelbine weekly. Twenty-four patients were eligible for response and for toxicity. Partial response was observed in 3 out of 24 eligible patients (12.5%; 95% confidence interval, 2.7-32.4%). All 3 patients who responded had previous chemotherapy including vincristine. The most common toxicity was leukopenia (91.7%, 66.7% in WHO 3-4 grade) and anemia (70.8%, 20.8% in WHO 3 grade). Nonhematological toxicities were moderate and mild. These results support a two-state sequential study design of previously untreated patients for further phase II study in SCLC.

Citations

Feb 20, 2009·International Journal of Clinical Oncology·Tsuneo ShimokawaAkihiko Gemma
Dec 14, 2005·Current Treatment Options in Oncology·Kristen Keon Ciombor, Caio Max S Rocha Lima
May 16, 2002·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Cesare GridelliFrancesco Perrone
Jul 9, 2003·Clinical Oncology : a Journal of the Royal College of Radiologists·H J MackayD J Dunlop
Mar 12, 2004·Critical Reviews in Oncology/hematology·Miklos SimonJohn R Murren
Jun 22, 2011·Nature Reviews. Clinical Oncology·William N William, Bonnie S Glisson
Mar 5, 2005·Anti-cancer Drugs·Sanjay Popat, Mary O'Brien
Apr 19, 2011·Clinical Medicine Insights. Oncology·Tatsuo KimuraKazuto Hirata
Mar 14, 2003·Seminars in Oncology·Alan B Sandler
Mar 14, 2003·Seminars in Oncology·Bonnie S Glisson
Apr 21, 2011·Expert Review of Anticancer Therapy·Alexander Schmittel
Sep 1, 2007·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Marcello Tiseo, Andrea Ardizzoni
Feb 9, 2013·Seminars in Oncology·James Smith, Diane Reidy-Lagunes
Sep 11, 2010·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Akito HataKeisuke Tomii
Dec 11, 2008·Cancer Treatment Reviews·Annemiek M E WalenkampDirk T Sleijfer
Sep 26, 2003·Seminars in Surgical Oncology·Frank B ZimmermannBranislav Jeremic
Apr 20, 2004·Hematology/oncology Clinics of North America·Angela M DaviesFrances A Shepherd
Aug 17, 1999·Cancer Treatment Reviews·C HuismanE F Smit
Jan 28, 2010·British Journal of Cancer·M PuglisiM E R O'Brien
Jun 13, 2018·Journal of Oncology Practice·Jun Gong, Ravi Salgia
Jul 13, 2002·Expert Review of Anticancer Therapy·G A Daniels, A A Adjei
Dec 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sayaka OnodaUNKNOWN Thoracic Oncology Research Group Study 0301
Oct 16, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Akira InoueToshihiro Nukiwa
Dec 18, 2003·Journal of Experimental Therapeutics & Oncology·Evan PisickRavi Salgia
Aug 30, 2017·Expert Review of Anticancer Therapy·Nathalie BaizeChristos Chouaid
Mar 10, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S PignataS Tramontana
Jun 6, 2015·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Tak YunJin Soo Lee
Mar 18, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J von PawelR Gralla
May 14, 2020·Clinics in Chest Medicine·Andreas Saltos, Scott Antonia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
J JassemN van Zandwijk
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Gregory A MastersEastern Cooperative Oncology Group
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
P E PostmusT A Splinter
Clinical Oncology : a Journal of the Royal College of Radiologists
S J FalkN M Bleehen
© 2021 Meta ULC. All rights reserved